Based on these findings, we speculate that mesothelial ITGA2 may directly increase the adhesive capability of mesothelial cells through collagen-mediated adhesion and that VEGFC may contribute to adhesion by acting as an inducer of adhesion-related gene expression and signaling pathways in both mesothelial and cancer cells. Here, VEGFC is linked to cancer.